JLJianyu Lai

Jianyu Lai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jianyu Lai has a total of 68 co-authors. Here are the top co-authors by number of shared publications:

  • Donald Kirby Milton

    Affiliations Department of Global, Environmental, and Occupational Health, School of Public Health, University of Maryland, College Park, Maryland, United States of America, Fischell Institute for Biomedical Devices, University of Maryland, College Park, Maryland, United States of America

    12 shared publications
  • Filbert Hong

    Department of Global, Environmental, and Occupational Health University of Maryland School of Public Health College Park Maryland USA

    6 shared publications
  • Filbert Hong

    University of Maryland School of Public Health

    5 shared publications
  • S.-H. Sheldon Tai

    Department of Global

    5 shared publications
  • Jennifer German

    Maryland Institute for Applied Environmental Health, University of Maryland School of Public Health, College Park, MD, USA

    4 shared publications
  • Yi Esparza

    Department of Global

    4 shared publications

Latest Publications

  • Open Access

    Impact of Ventilation on Respiratory Virus Transmission in College Residence Hall Cohorts: Potential for Causal Inference About Mode of Transmission

    by T. Louis Gold, Kathleen M. McPhaul, Huang Lin, Ryan Doughty, Irina Maljkovic Berry, Filbert Hong, Jianyu Lai, Todd J. Treangen, Jelena Srebric, Donald K. Milton

    Background: The SARS‐CoV‐2 pandemic focused attention on airborne‐inhalation transmission and building ventilation. However, investment in solutions lags because few epidemiologic studies demonstrate a causal effect of ventilation on acute respiratory infection (ARI) transmission. This highlights a need for improved study designs to support causal inference.Methods: To investigate the potential for causal inference, we analyzed prospective cohorts residing in a high‐ventilation (HVent, ≥ 5 L/s per person) or a neighboring low‐ventilation (LVent, < 5 L/s per person) college residence hall during two spring semesters (2018 and 2019). Swab samples, analyzed using a PCR panel for respiratory pathogens, were collected based on self‐reported symptoms and contacts. Our analysis focused on roommate pairs where both had been tested within a 2‐week period. Roommate pairs with concordant positive PCR results were categorized as possible transmission events. We used genetic sequencing and phylogenetic analysis to identify probable transmission clusters and events.Results: We analyzed data from 368 cohort participants (82 HVent and 286 LVent), including 60 person‐infections, with a trend toward 54% lower ARI risk among students living in HVent versus LVent residence halls. We identified 97 roommate pairs, 64 two‐week intervals where both members were tested, 36 (2 HVent and 34 LVent) intervals with ≥ 1 infection, and four possible transmission events (all LVent). Sequence data available for two of the four events confirmed one probable transmission cluster and one probable transmission event.Conclusions: Future college dorm transmission studies should prioritize enrolling roommates rather than individuals, measuring ventilation, and confirming transmission events through whole genome sequencing.


  • Open Access

    Comparison of Viral Aerosol Shedding by Mild and Moderately Symptomatic Community‐Acquired and Nasally Inoculated Influenza A(H3) Infection

    by Jianyu Lai, P. Jacob Bueno de Mesquita, Filbert Hong, Tianzhou Ma, Benjamin J. Cowling, Donald K. Milton

    Background: Nasally inoculated influenza cases reported milder symptoms and shed lower viral RNA load in exhaled breath aerosols (EBA) than people with classic influenza‐like illness in a previous study. Whether nasally inoculated influenza is representative of mild natural influenza infection is unknown. We extend previous analyses to include a broader range of community‐acquired cases.Methods: We previously studied (A) volunteers intranasally inoculated with a dose of 5.5 log10TCID50 of influenza A/Wisconsin/67/2005 (H3N2) and (B) cases with classic influenza‐like illness including fever recruited in 2013. We now add (C) cases from a 2017–2019 surveillance cohort of college dormitory residents and their contacts and (D) cases from a university health center in 2019. All cases had an influenza A(H3) infection. We collected 30‐min EBA samples using a Gesundheit‐II sampler.Results: Community‐acquired cases from the surveillance cohort (C) shed more EBA viral RNA and were more symptomatic than the inoculated cases (A) but shed less viral RNA than the symptom‐selected natural cases (B) from 2013, but not (D) from 2019. Despite similar symptoms to the 2013 selected cases (B), the 2019 community‐acquired cases (D) recruited post‐infection had lower fine aerosol viral RNA.Conclusions: Nasal inoculation of influenza virus did not reproduce EBA viral RNA shedding or symptoms observed in mild natural infection. Circulating strains of influenza A(H3) may differ year‐to‐year in the extent to which symptomatic cases shed virus into fine aerosols. New models, including possibly aerosol inoculation, are needed to study viral aerosol shedding from the human respiratory tract.


  • Open Access

    Evaluating Modes of Influenza Transmission (EMIT-2): Insights from a Controlled Human Influenza Virus Infection Transmission Trial (CHIVITT)

    by Jianyu Lai, Hamed Sobhani, Kristen K. Coleman, S.-H. Sheldon Tai, Filbert Hong, Isabel Sierra Maldonado, Yi Esparza, Kathleen M. McPhaul, Shengwei Zhu, Don L. DeVoe, et al.

    A previous controlled human influenza transmission trial produced minimal transmission using nasal inoculation of an egg adapted virus. Therefore, we implemented a new trial with naturally infected Donors. We recruited healthy Recipients for four, two-week hotel quarantine cohorts and naturally infected, qRT-PCR confirmed Donors for two cohorts. Five Donors (mean age: 21; 80% female; two H1N1, three H3N2, one for cohort 24b and 4 for 24c, Jan-Feb 2024) exposed Recipients (mean age: 36; 55% female, eight in cohort 24b and 3 in 24c) in a hotel room with limited ventilation but a high air recirculation rate. We collected exhaled breath, ambient and personal bioaerosols, fomite swabs, and sera, and analyzed samples using dPCR and fluorescent focus assays, hemagglutination inhibition (HAI) assay, and enzyme-linked immunosorbent assay (ELISA). Compared with previously studied community-acquired influenza cases, we detected viral RNA (44%) and culturable virus (6%) less frequently and measured fewer viral RNA copies (79 – 8.9×10 3 copies/30-min) in Donors’ exhaled fine aerosols. One of 23 surface swab samples was culture positive. At admission, 8 of 11 Recipients had HAI titers ≤10 but 9 of 11 had stronger binding antibody responses than Donors against vaccine strains corresponding to Donor viruses. No Recipient developed influenza-like illness, PCR-positive respiratory samples, or serological evidence of infection. Potential explanations and insights regarding lack of transmission include importance of cough and seasonal variation in viral aerosol shedding by Donors, of potential cross-reactive immunity in middle-aged Recipients with decades of exposure, and of exposure to concentrated exhaled breath plumes limited by rapid air mixing from environmental controls that distributed aerosols evenly. Future trials over multiple seasons, Donors that cough, younger recipients, and environments that preserve normal exhaled breath plumes will be required to observe transmission from naturally infected Donors under controlled conditions and generate new insights into influenza transmission dynamics. Author Summary: Human-to-human influenza virus transmission under controlled conditions could provide insights leading to better control of epidemics and pandemics. However, a previous study using laboratory adapted viruses produced minimal transmission. Therefore, we aimed to study transmission from people naturally infected with circulating viruses. We recruited four cohorts of healthy volunteer Recipients to stay in a quarantine hotel for two weeks. We could not recruit Donors for the first two cohorts. In the last two cohorts, one Donor exposed eight Recipients in the first and four Donors exposed three Recipients in the second. The Donors coughed infrequently and shed less virus into the air than we had observed during previous influenza seasons. No Recipients became infected. Possible explanations include that people infected during mild influenza seasons or who cough very little may be minimally contagious. Our middle-aged Recipient cohorts were older than Donors and possibly less susceptible to infection because of additional years of vaccination and infection. Finally, environmental controls in the hotel distributed aerosols evenly but reduced short-range exposure to concentrated clouds of exhaled breath that may play an important role in transmission. New designs will need to address these issues.

  • Open Access

    Impact of ventilation on respiratory virus transmission in college residence hall cohorts: potential for causal inference about mode of transmission

    by T. Louis Gold, Kathleen M. McPhaul, Huang Lin, Ryan Doughty Doughty, Irina Maljkovic Berry, Filbert Hong, Jianyu Lai, Todd J. Treangen, Jelena Srebric, Donald Milton

    The SARS-CoV-2 pandemic focused attention on the importance of ventilation to limit acute respiratory infection (ARI) transmission. However, because few epidemiologic studies demonstrate a causal effect of building ventilation on ARI transmission investment in solutions remains at risk. We report results of a two-year ARI study of college students living in campus residence halls with a trend toward 54% lower ARI risk with higher ventilation. Our analysis suggests that the most powerful causal analysis can be derived from focusing on roommate pairs. Future studies should prioritize enrolling roommates rather than individuals and confirm transmission events through whole genome sequencing.

  • Open Access

    Influenza A (H3) viral aerosol shedding in nasally inoculated and naturally infected cases

    by Jianyu Lai, P. Jacob Bueno de Mesquita, Filbert Hong, Tianzhou Ma, Benjamin J. Cowling, Donald K. Milton

    Nasally inoculated influenza cases reported milder symptoms and shed lower viral RNA load in exhaled breath aerosols (EBA) than people with classic influenza-like illness including fever, in a previous study. Whether nasally inoculated influenza is representative of mild natural influenza infection, the majority of natural infections, is unknown. Here, we extend our previous analyses to include a broader range of community-acquired influenza cases. Previously, we reported on two groups: (A) volunteers intranasally inoculated with a dose of 5.5 log 10 TCID 50 of influenza A/Wisconsin/67/2005 (H3N2) and (B) cases with cough and sore throat plus fever or a positive rapid antigen test recruited on a college campus in the same year (2013). Here we added two additional groups from a later study: (C) cases from a 2017-2019 surveillance cohort of college dormitory residents and their contacts, and (D) cases recruited from a university health center in 2019. All cases had an influenza A(H3) infection. Using a Gesundheit-II sampler, we collected 30-minute EBA samples. Community-acquired cases from the surveillance cohort (C) shed more EBA viral RNA and were more symptomatic than the nasally inoculated cases (A) but shed less viral RNA than the natural cases that were selected for symptoms (B) in 2013, but not (D) recruited in 2019. Despite sharing a similar symptomatic profile with the 2013 selected natural cases (B), the 2019 community-acquired cases (D) recruited post-infection showed a lower fine aerosol viral RNA load. Nasal inoculation of influenza virus did not reproduce EBA viral RNA shedding or symptoms observed in mild natural infection. Circulating strains of influenza A(H3) may differ, year-to-year in the extent to which symptomatic cases shed virus into fine aerosols. New models, including possibly aerosol inoculation, are needed to study viral aerosol shedding from the human respiratory tract. Author Summary: In this study, we compared influenza A (H3) viral aerosol shedding in the exhaled breath of four different groups of influenza cases: (A) volunteers given the influenza virus intranasally, naturally infected (B) college community members with classic influenza-like illness including fever recruited in 2013, (C) dormitory residents undergoing active surveillance, and (D) patients from a university health center recruited in 2019. We found that mild symptomatic cases among healthy college students (C) released more viral RNA in their exhaled breath than those nasally inoculated with influenza virus (A). We also observed that more symptomatic and medically attended cases from different flu seasons (B and D), although reporting similar symptom severity, shed different levels of viral RNA in their exhaled breath. Our findings indicate that influenza viral aerosol shedding varies from season to season. Most volunteers nasally inoculated at a high virus dose did not shed detectable viral RNA in their exhaled breath or show symptoms, suggesting that nasal inoculation may not accurately mimic natural infection. Our results highlight the need for improved models to study the spread of influenza virus in aerosol forms.

  • Open Access

    Relative efficacy of masks and respirators as source control for viral aerosol shedding from people infected with SARS-CoV-2: a controlled human exhaled breath aerosol experimental study

    by Jianyu Lai, Kristen K. Coleman, S.-H. Sheldon Tai, Jennifer German, Filbert Hong, Barbara Albert, Yi Esparza, Dewansh Rastogi, Aditya Srikakulapu, Petri Kalliomäki, et al.


  • Open Access

    Exhaled Breath Aerosol Shedding of Highly Transmissible Versus Prior Severe Acute Respiratory Syndrome Coronavirus 2 Variants

    by Jianyu Lai, Kristen K Coleman, S H Sheldon Tai, Jennifer German, Filbert Hong, Barbara Albert, Yi Esparza, Aditya K Srikakulapu, Maria Schanz, Isabel Sierra Maldonado, et al.

    Background: Aerosol inhalation is recognized as the dominant mode of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Three highly transmissible lineages evolved during the pandemic. One hypothesis to explain increased transmissibility is that natural selection favors variants with higher rates of viral aerosol shedding. However, the extent of aerosol shedding of successive SARS-CoV-2 variants is unknown. We aimed to measure the infectivity and rate of SARS-CoV-2 shedding into exhaled breath aerosol (EBA) by individuals during the Delta and Omicron waves and compared those rates with those of prior SARS-CoV-2 variants from our previously published work.Methods: Individuals with coronavirus disease 2019 (COVID-19) (n = 93; 32 vaccinated and 20 boosted) were recruited to give samples, including 30-minute breath samples into a Gesundheit-II EBA sampler. Samples were quantified for viral RNA using reverse-transcription polymerase chain reaction and cultured for virus.Results: Alpha (n = 4), Delta (n = 3), and Omicron (n = 29) cases shed significantly more viral RNA copies into EBAs than cases infected with ancestral strains and variants not associated with increased transmissibility (n = 57). All Delta and Omicron cases were fully vaccinated and most Omicron cases were boosted. We cultured virus from the EBA of 1 boosted and 3 fully vaccinated cases.Conclusions: Alpha, Delta, and Omicron independently evolved high viral aerosol shedding phenotypes, demonstrating convergent evolution. Vaccinated and boosted cases can shed infectious SARS-CoV-2 via EBA. These findings support a dominant role of infectious aerosols in transmission of SARS-CoV-2. Monitoring aerosol shedding from new variants and emerging pathogens can be an important component of future threat assessments and guide interventions to prevent transmission.


  • Open Access

    Comparison of Saliva and Midturbinate Swabs for Detection of SARS-CoV-2

    by Jianyu Lai, Jennifer German, Filbert Hong, S.-H. Sheldon Tai, Kathleen M. McPhaul, Donald K. Milton

    The findings of this manuscript are increasingly important with new variants that appear to have shorter incubation periods emerging, which may be more prone to detection in saliva before detection in nasal swabs. Therefore, there is an urgent need to provide the science to support the use of a detection method that is highly sensitive and widely acceptable to the public to improve screening rates and early detection.


  • Open Access

    Initial Assessment of SARS-CoV-2 Omicron Variant in Exhaled Breath Aerosol

    by Donald K. Milton, S.-H. Sheldon Tai, Jennifer German, Filbert H. Hong, Barbara Albert, Yi Esparza, Aditya K Sirkakulapu, Maria Schanz, Jianyu Lai, Isabel Sierra Sierra Maldonado, et al.

    From December 16 through 21 of 2021, we collected exhaled breath aerosol (EBA) from five members of a University campus community infected with SARS-CoV-2 viruses displaying an S-gene target failure when assayed using the TaqPath COVID-19 Real Time PCR Assay (Thermo Scientific).

  • Open Access

    Comparison of Saliva and Mid-Turbinate Swabs for Detection of COVID-19

    by Jianyu Lai, Jennifer German, Filbert Hong, S.-H. Sheldon Tai, Kathleen M. McPhaul, Donald K. Milton, for the University of Maryland StopCOVID Research Group

    Background Saliva is an attractive sample for detecting SARS-CoV-2 because it is easy to collect and minimally invasive. However, contradictory reports exist concerning the sensitivity of saliva versus nasal swabs. Methods We recruited and followed close contacts of COVID-19 cases for up to 14 days from their last exposure and collected self-reported symptoms, mid-turbinate swabs (MTS) and saliva every two or three days. Ct values and frequency of viral detection by MTS and saliva were compared. Logistic regression was used to estimate the probability of detection by days since symptom onset for the two sample types. Results We enrolled 58 contacts who provided a total of 200 saliva and MTS sample pairs; 14 contacts (13 with symptoms) had one or more positive samples. Overall, saliva and MTS had similar rates of viral detection (p=0.78). Although Ct values for saliva were significantly greater than for MTS (p=0.014), Cohen’s Kappa demonstrated substantial agreement (κ=0.83). However, sensitivity varied significantly with time relative to symptom onset. Early in the course of infection (days -3 to 2), saliva had 12 times (95%CI: 1.2, 130) greater likelihood of detecting viral RNA compared to MTS. After day 2, there was a non-significant trend to greater sensitivity using MTS samples. Conclusion Saliva and MTS specimens demonstrated high agreement, making saliva a suitable alternative to MTS nasal swabs for COVID-19 detection. Furthermore, saliva was more sensitive than MTS early in the course of infection, suggesting that it may be a superior and cost-effective screening tool for COVID-19. Key Points Saliva is more sensitive in detecting symptomatic cases of COVID-19 than MTS early in the course of infection. Saliva performs best in the pre-symptomatic period. Saliva and MTS demonstrated high agreement making saliva a suitable and cost-effective COVID-19 screening tool.